Two Sigma Advisers’s CorMedix CRMD Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-51,900
| Closed | -$192K | – | 2524 |
|
2023
Q3 | $192K | Buy |
51,900
+37,900
| +271% | +$140K | ﹤0.01% | 2105 |
|
2023
Q2 | $55.5K | Sell |
14,000
-34,600
| -71% | -$137K | ﹤0.01% | 2266 |
|
2023
Q1 | $201K | Buy |
48,600
+3,100
| +7% | +$12.8K | ﹤0.01% | 2266 |
|
2022
Q4 | $192K | Sell |
45,500
-8,400
| -16% | -$35.4K | ﹤0.01% | 2202 |
|
2022
Q3 | $153K | Sell |
53,900
-37,200
| -41% | -$106K | ﹤0.01% | 2253 |
|
2022
Q2 | $366K | Buy |
91,100
+42,200
| +86% | +$170K | ﹤0.01% | 2055 |
|
2022
Q1 | $268K | Sell |
48,900
-34,600
| -41% | -$190K | ﹤0.01% | 2274 |
|
2021
Q4 | $380K | Sell |
83,500
-75,500
| -47% | -$344K | ﹤0.01% | 2047 |
|
2021
Q3 | $739K | Sell |
159,000
-44,300
| -22% | -$206K | ﹤0.01% | 1756 |
|
2021
Q2 | $1.4M | Buy |
203,300
+25,600
| +14% | +$176K | ﹤0.01% | 1482 |
|
2021
Q1 | $1.78M | Sell |
177,700
-36,300
| -17% | -$363K | ﹤0.01% | 1323 |
|
2020
Q4 | $1.59M | Buy |
214,000
+91,900
| +75% | +$683K | ﹤0.01% | 1373 |
|
2020
Q3 | $736K | Buy |
122,100
+108,300
| +785% | +$653K | ﹤0.01% | 1643 |
|
2020
Q2 | $87K | Buy |
+13,800
| New | +$87K | ﹤0.01% | 2376 |
|
2019
Q1 | – | Sell |
-2,240
| Closed | -$14K | – | 2322 |
|
2018
Q4 | $14K | Buy |
+2,240
| New | +$14K | ﹤0.01% | 2322 |
|